BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6346786)

  • 1. Pseudomesotheliomatous carcinoma of the lung with histochemical and immunohistochemical study.
    Nishimoto Y; Ohno T; Saito K
    Acta Pathol Jpn; 1983 Mar; 33(2):415-23. PubMed ID: 6346786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomesotheliomatous carcinoma of the lung. A variant of peripheral lung cancer.
    Harwood TR; Gracey DR; Yokoo H
    Am J Clin Pathol; 1976 Feb; 65(2):159-67. PubMed ID: 175652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic histochemical and immunohistochemical studies in malignant mesothelioma.
    Lucas JG; Tuttle SE
    J Surg Oncol; 1987 May; 35(1):30-4. PubMed ID: 2437407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucin-positive epithelial mesotheliomas: a histochemical, immunohistochemical, and ultrastructural comparison with mucin-producing pulmonary adenocarcinomas.
    Hammar SP; Bockus DE; Remington FL; Rohrbach KA
    Ultrastruct Pathol; 1996; 20(4):293-325. PubMed ID: 8837337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pseudomesotheliomatous carcinoma of the lung].
    Maeda R; Isowa N; Kawasaki Y; Tokuyasu H; Itakura A; Miura H; Onuma H
    Kyobu Geka; 2007 Jul; 60(7):555-8. PubMed ID: 17642217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural, and immunohistologic study of 103 cases.
    Wick MR; Loy T; Mills SE; Legier JF; Manivel JC
    Hum Pathol; 1990 Jul; 21(7):759-66. PubMed ID: 2193875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The forensic significance of pseudomesotheliomatous adenocarcinoma of the lung.
    Kennedy JM
    Forensic Sci Med Pathol; 2019 Sep; 15(3):458-462. PubMed ID: 30927189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical comparison of diffuse malignant mesothelioma of the pleura and pseudomesotheliomatous carcinoma of the lung for each case].
    Yuasa H; Tomoyasu M
    Kyobu Geka; 1999 Sep; 52(10):836-9. PubMed ID: 10478545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma.
    Kobashi Y; Matsushima T; Irei T
    Respirology; 2005 Nov; 10(5):660-5. PubMed ID: 16268922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of adenocarcinoma of the lung from mesothelioma. Periodic acid-Schiff, monoclonal antibodies B72.3, and Leu M1.
    Warnock ML; Stoloff A; Thor A
    Am J Pathol; 1988 Oct; 133(1):30-8. PubMed ID: 2845790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Evaluation of the application of morphometry combined with histochemistry and immunostaining.
    Kwee WS; Veldhuizen RW; Golding RP; Mullink H; Stam J; Donner R; Boon ME
    Virchows Arch A Pathol Anat Histol; 1982; 397(3):287-99. PubMed ID: 6186071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case reports of primary pulmonary adenocarcinoma with pleural spread: so-called pseudomesotheliomatous adenocarcinoma.
    Saito R; Kasajima A; Taniuchi S; Fujishima F; Ishida K; Nakamura Y; Yamanda S; Takahashi T; Hitomi H; Murakami K; Watanabe M; Sasano H
    Pathol Int; 2012 Oct; 62(10):709-15. PubMed ID: 23005599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pleuropulmonary tumors. Presentation of 2 cases with peculiar clinicopathologic traits].
    Esquius Soriguera J; Alejo Sánchez M; Padilla Navas I; Rodríguez Casquero C; León González C
    Rev Clin Esp; 1989 Oct; 185(6):303-5. PubMed ID: 2623239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma simulating mesothelioma: a clinicopathologic and immunohistochemical study of 29 cases.
    Koss MN; Fleming M; Przygodzki RM; Sherrod A; Travis W; Hochholzer L
    Ann Diagn Pathol; 1998 Apr; 2(2):93-102. PubMed ID: 9845725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.
    Brown RW; Clark GM; Tandon AK; Allred DC
    Hum Pathol; 1993 Apr; 24(4):347-54. PubMed ID: 7684019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomesotheliomatous carcinoma of the lung.
    Vuković J; Plavec G; Aćimović S; Jović M; Stojsavljević M; Trimčev J; Nikolajević S; Skuletić V; Lončarević O; Živković V; Zolotarevska L; Cerović S
    Vojnosanit Pregl; 2016 Dec; 73(12):1168-72. PubMed ID: 29341576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of triple malignancies (gastric cancer, lung cancer and malignant pleural mesothelioma) after asbestos exposure].
    Kishimoto T
    Nihon Kokyuki Gakkai Zasshi; 2003 Apr; 41(4):304-9. PubMed ID: 12795187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytologic diagnosis of mesothelioma.
    Ehya H
    Semin Diagn Pathol; 1986 Aug; 3(3):196-203. PubMed ID: 3616223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous occurrence of pulmonary adenocarcinoma and pleural diffuse malignant mesothelioma.
    Imenpour H; Ivaldi GP; Brianti A; Pastorino G; Biggi S; Auriati L; Simonassi C
    Pathologica; 2013 Dec; 105(6):353-6. PubMed ID: 24730341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma.
    Holden J; Churg A
    Am J Surg Pathol; 1984 Apr; 8(4):277-9. PubMed ID: 6201076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.